Close

CTI BioPharma (CTIC) Prices $55M Conv. Preferred Offering

December 4, 2015 11:19 AM EST Send to a Friend
CTI BioPharma Corp. ("CTI") (Nasdaq: CTIC) announced the pricing of an underwritten public offering of 55,000 shares of its Series ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login